

We’ll strive to achieve this vision by transforming into a center of excellence that informs health policies and delivery of quality services collaboratively through research, innovation, capacity strengthening and program implementation.
Ifakara Health Institute (IHI) is a leading health research organization in Africa, with a strong track record of developing, testing and validating innovations for health. We are driven by core strategic mandate for research, training and services. Ifakara encompasses a broad range of scientific disciplines, spanning from basic biomedical and ecological sciences to clinical trials, health systems research, policy translation, and health program implementation.
Our Data Repository serves as a centralized hub for all data-related resources, ensuring easy access and efficient management of our organization's valuable information.
Explore moreThe Study on the Policy Ecology of China-Africa Cooperation for Malaria Control and the Impact of 1,7-malaria Reactive Community Testing and Response (1,7-mRCTR) aims to assess the real-world impact of the 1,7-mRCTR strategy and to understand the context in which it …
The BNT166-02 study is a Phase II clinical trial evaluating the safety, reactogenicity, and immunogenicity of BNT166a, a next-generation mRNA-based vaccine developed by BioNTech to prevent mpox (monkeypox). The study focuses on healthy individuals aged 12 years and a…
This project aims to evaluate the efficacy, safety, and immunogenicity of the MTBVAC vaccine candidate in preventing tuberculosis (TB) among adolescents and adults aged 14-45 years, living in TB-endemic regions.